Sana Biotechnology Inc vs Target Corporation — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Target Corporation trades at $138.64 (market cap $63.40B). The key difference: Target Corporation is far larger — about 72.6× Sana Biotechnology Inc's market cap, and Target Corporation pays a 3.32% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | TGT | |
|---|---|---|
Market Cap | $873.84M | $63.40B |
Sector | Health | Consumer Cyclical |
52-Week High | $5.92 | $141.19 |
52-Week Low | $2.68 | $83.68 |
Enterprise Value | $848.03M | $78.70B |
Dividend Yield | — | 3.32% |
Trailing returns across standard periods
Latest headlines on both assets
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →